| Episode | Status |
|---|---|
| Episode | Status |
|---|---|
Today's guest is Robert Wenier, Global Head of Cloud and Infrastructure at AstraZeneca. Robert leads enterprise cloud, infrastructure, and platform strategy across a highly regulated, data-intensive g...
Robert Wenier, Global Head of Cloud and Infrastructure at AstraZeneca, discusses the fundamental shift from service-oriented architectures to agentic systems that prioritize direct business outcomes over stepwise technical execution. The conversation explores how AI is transforming infrastructure design, moving decision-making authority from departments to individuals, and eliminating data logistics work through intelligent agents. Wenier emphasizes that competitive advantage now depends on speed to value rather than efficiency, requiring enterprises to rethink traditional vendor relationships and technology ownership models.
Wenier traces the architectural evolution from service-oriented architectures (SOA) through microservices to emerging agentic architectures. Unlike previous paradigms focused on stepwise technical execution, agentic systems aim to deliver end-to-end business outcomes directly, fundamentally changing how infrastructure supports business goals.
The fundamental shift from technology as a business enabler to a business discriminator represents a major paradigm change. Previously, technology enabled stepwise processes; now it directly drives competitive advantage by delivering business outcomes without intermediate technical steps.
AI is enabling value creation to move from corporate and business unit levels down to teams and individuals. The shift transforms workers from 'cogs in a machine' to 'the machine itself,' with each unit expected to deliver direct business value rather than technical outputs.
AI agents can eliminate the manual logistics of moving data between systems, allowing professionals to make strategic decisions directly at the data source. This removes entire categories of work focused on data formatting, transfer, and preparation.
Profitability has shifted from efficiency-based models to speed-to-market and speed-to-value models. Technology's primary purpose is now accelerating business outcomes, with companies needing to outpace competitors in decision-making and value realization rather than just reducing costs.
In pharma, high selling, general, and administrative (SG&A) expenses reduce research and development investment. Streamlining processes through AI to reduce SG&A burden enables faster speed to value and reinvestment in R&D, creating a competitive cycle of acceleration.
Many large SaaS providers view AI as a tool to add to existing platforms rather than recognizing it as a fundamental paradigm shift. This misreading threatens their business models as agentic architectures may eliminate the need for traditional large-scale SaaS platforms.
True industrialization means using AI to achieve complete business objectives from conception through commercialization, not just technical ends. This requires abstracting away traditional infrastructure concerns and focusing on business decision-making enabled by agents.
Winners in the AI age will be companies that don't feel constrained by traditional vendor relationships and licensing models. The shift requires adaptability to use whatever tools achieve business outcomes fastest, moving beyond strategic partnerships and license-based IT management.
Accelerating Speed to Value through Agentic Systems and Intelligent Automation in Life Sciences - with Robert Wenier of AstraZeneca
Ask me anything about this podcast episode...
Try asking: